Valuation: Guizhou Yibai Pharmaceutical Co., Ltd.

Market Cap 2.67B 393M 345M 320M 294M 556M 37.65B 567M 3.81B 1.49B 18.49B 1.48B 1.44B 63.85B P/E 2024
-8.86x
P/E 2025 -9.48x
Enterprise Value 2.88B 425M 373M 346M 318M 601M 40.71B 613M 4.12B 1.62B 19.99B 1.6B 1.56B 69.04B EV / Sales 2024
1.48x
EV / Sales 2025 1.79x
Free-Float
69.52%
Yield 2024 *
-
Yield 2025 -
1 day+2.41%
1 week+6.25%
Current month+14.48%
1 month+3.34%
3 months-29.31%
6 months-18.27%
Current year-14.57%
1 week 3.07
Extreme 3.07
3.46
1 month 2.85
Extreme 2.85
3.46
Current year 2.85
Extreme 2.85
5.27
1 year 2.85
Extreme 2.85
5.27
3 years 2.76
Extreme 2.76
6.15
5 years 2.76
Extreme 2.76
8.8
10 years 2.76
Extreme 2.76
20.3
Manager TitleAgeSince
Chief Executive Officer 42 2021-05-12
Director of Finance/CFO 52 2024-09-05
Corporate Officer/Principal 56 2019-09-16
Director TitleAgeSince
Chairman 66 2009-01-21
Director/Board Member 56 2011-02-20
Director/Board Member 42 2019-01-02
Change 5-day change 1-year change 3-year change Capi.($)
+2.41%+6.25%-17.27%-34.87% 384M
-0.04%-0.88%+48.80%+173.63% 1,060B
+0.33%-0.26%+64.93%+62.87% 619B
-0.12%-2.77%+29.33%+85.41% 438B
-1.75%-0.33%+28.33%+23.58% 333B
+0.24%-0.42%+29.19%+47.26% 282B
-1.75%-10.57%+18.27%+22.07% 267B
+0.67%+1.03%-26.81%-37.96% 218B
-0.83%-1.54%+21.46%+58.47% 196B
+1.23%+1.42%+17.28%+71.37% 161B
Average +0.11%-2.21%+21.35%+47.18% 357.43B
Weighted average by Cap. -0.14%-3.09%+35.93%+84.52%

Financials

2024 2025
Net sales 2.17B 321M 281M 260M 240M 453M 30.69B 462M 3.1B 1.22B 15.07B 1.2B 1.18B 52.05B 1.86B 275M 241M 223M 205M 388M 26.3B 396M 2.66B 1.04B 12.91B 1.03B 1.01B 44.6B
Net income -317M -46.78M -41.03M -38.01M -34.97M -66.14M -4.48B -67.43M -453M -178M -2.2B -176M -172M -7.59B -330M -48.6M -42.63M -39.48M -36.33M -68.72M -4.65B -70.05M -471M -185M -2.28B -183M -179M -7.89B
Net Debt 411M 60.6M 53.15M 49.23M 45.29M 85.67M 5.8B 87.34M 587M 230M 2.85B 228M 223M 9.84B 217M 32.02M 28.08M 26.01M 23.93M 45.27M 3.06B 46.15M 310M 122M 1.51B 120M 118M 5.2B
Logo Guizhou Yibai Pharmaceutical Co., Ltd.
Guizhou Yibai Pharmaceutical Co Ltd is a China-based company principally engaged in pharmaceutical industry, medical services, and big health industry businesses. The pharmaceutical industry business is mainly engaged in the research and development, production and sales of chemical drugs, traditional Chinese medicines, biological drugs and other drugs. The medical service business is mainly engaged in the operation and management of comprehensive hospitals, tumor specialty hospitals, and tumor radiotherapy centers. The big health industry business is mainly engaged in the development, research, production and sales of big health products featuring Miao medicine. The Company mainly operates its businesses in the domestic market.
Employees
4,832
Date Price Change Volume
26-07-12 CN¥3.400 +2.41% 36,638,170
26-07-10 CN¥3.320 +5.40% 35,226,991
26-07-09 CN¥3.150 -0.32% 13,205,327
26-07-08 CN¥3.160 +0.32% 15,263,713
26-07-07 CN¥3.150 -4.26% 18,555,800
  1. Stock Market
  2. Stocks
  3. 600594 Stock